Request A Project Quote
Request A Project Quote

Complete Plasmid/Phage Sequencing

CD Genomics provides complete plasmid and phage sequencing services. Our advanced bioinformatics pipelines support de novo assembly, eliminating the need for reference genomes and enabling thorough and precise analysis of both plasmids and bacteriophages.

What is Complete Plasmid/Phage Sequencing

Plasmids are circular DNA molecules that exist independently within bacterial cells, often carrying genes that endow their host with beneficial traits such as antibiotic resistance or enhanced metabolic functions. These plasmids are essential for horizontal gene transfer, allowing bacteria to swiftly adapt to environmental pressures and change. Similarly, phages, or bacteriophages, are viruses that specifically target bacteria and play a crucial role in bacterial gene transfer and population dynamics. Their interactions with bacterial hosts impact microbial diversity and ecological balance.

A thorough understanding of the genetic structure of plasmids and phages is vital for grasping their roles in microbial ecosystems and their influence on traits like antibiotic resistance. Complete Plasmid/Phage Sequencing involves decoding the entire genetic sequence of plasmids and phages, offering an extensive view of their genetic landscape. This method allows researchers to identify both the essential genes and the accessory elements that contribute to the organism's adaptability and pathogenic potential. Through this detailed genetic mapping, we gain deeper insights into microbial evolution and gene transfer processes, which are crucial for advancing research in biotechnology and environmental science.

Our Whole Plasmid/Phage Sequencing Methods

Plasmids and phages exhibit considerable variability in size and complexity, with plasmids often showing high GC content, intricate structures, or extensive repetitive regions, while phages can also display diverse genetic architectures and variable genome sizes. These complexities have historically made traditional Sanger sequencing methods both expensive and prone to high failure rates, coupled with relatively slow processing times.

Aspect Sanger Sequencing Whole Plasmid/Phage Sequencing (NGS)
Methodology Chain-termination method Utilizes Next-Generation Sequencing (NGS) or Long Read Sequencing technologies
Sequence Length Suitable for shorter fragments (up to 1,000 bp) Capable of sequencing entire plasmids and phages, regardless of size or complexity
Speed Sanger Sequencing can involve extended processing times and is particularly suited for small-scale projects. Whole Plasmid/Phage Sequencing using NGS technologies offers a faster turnaround, ideal for high-throughput applications
Cost Can be cost-prohibitive for larger plasmids due to multiple sequencing reactions Generally more cost-effective, especially for larger plasmids and phages, as it requires fewer sequencing reactions
Accuracy Sanger Sequencing is renowned for its high precision and minimal error rates Whole Plasmid/Phage Sequencing maintains exceptional accuracy and incorporates advanced error correction methods
Applicability Sanger Sequencing is effective for smaller plasmids but may face challenges with larger, intricate, or repetitive structures Whole Plasmid/Phage Sequencing is highly versatile, accommodating a wide range of plasmid and phage sizes and complexities, making it suitable for comprehensive genomic analysis

CD Genomics employs advanced sequencing technologies to deliver complete plasmid and phage DNA sequences. Our methods integrate both next-generation sequencing (NGS) and long-read sequencing technologies to accommodate the diverse structures and sizes of plasmids and phages. We utilize state-of-the-art platforms such as Illumina for high-throughput sequencing and Nanopore or PacBio for long-read sequencing. Our approach includes comprehensive library preparation and bioinformatics analysis, ensuring accurate assembly and annotation of the entire genetic sequence.

Advantages of Complete Plasmid/Phage Sequencing

Comprehensive Coverage: Provides full-length sequencing of plasmids and phages, including regions with high GC content and intricate structures that traditional methods might miss, ensuring a complete genetic overview.

High Accuracy: Delivers sequences with accuracy exceeding 99.9%, ensuring the genetic information is precise and dependable for further research.

Cost-Effective: Offers a more affordable solution, especially for large plasmids and phages, with costs significantly lower compared to traditional sequencing methods, making it a cost-efficient choice for extensive projects.

Rapid Turnaround: Ensures quick processing and data acquisition, accelerating research and enabling timely insights.

No Reference Required: Performs sequencing without the need for pre-existing reference genomes, ideal for exploring novel or uncharacterized plasmids and phages.

High Throughput: Capable of handling multiple samples simultaneously, enhancing efficiency and supporting large-scale research efforts.

Applications of Complete Plasmid/Phage Sequencing

  • Microbial Ecology: Examine the role of plasmids and phages within microbial communities, their interactions, and their influence on microbial diversity and ecosystem functions.
  • Gene Transfer Studies: Investigate horizontal gene transfer mechanisms mediated by plasmids and phages, including the dissemination of resistance genes and other functional attributes.
  • Synthetic Biology: Utilize comprehensive plasmid sequences to design and refine genetic constructs, advancing applications in synthetic biology.
  • Phage Research: Analyze phage genomes to develop strategies for targeted interventions against specific bacterial species.
  • Environmental Research: Explore the presence and functions of plasmids and phages across diverse environments, such as soil, water, and various microbial habitats.

Complete Plasmid/ Phage Sequencing Workflow

Workflow of Complete Plasmid/Phage Sequencing.

Service Specifications

Sample Requirements
Complete Plasmid DNA Sequencing:
  • Plasmid DNA≥ 1 µg;
  • Minimum Quantity: 500 ng;
  • Concentration ≥ 20 ng/µL
Plasmid Sequencing (Nanopore):
  • Genomic DNA≥ 1 µg;
  • Minimum Quantity: 500 ng;
  • Concentration ≥ 10 ng/µL
PhageSequencing
  • Sample Type: Phage samples can be either isolated from environmental samples or pure cultures.
Note: Sample amounts are listed for reference only. For detailed information, please contact us with your customized requests.

Click
Sequencing Strategy
Bioinformatics Analysis
We provide multiple customized bioinformatics analyses:
  • Data quality control
  • High-quality data acquisition
  • Genome de novo assembly
  • Detection of specific sequences
  • Annotation and functional analysis
Note: Recommended data outputs and analysis contents displayed are for reference only. For detailed information, please contact us with your customized requests.

Analysis Pipeline

The Data Analysis Pipeline of Complete Plasmid/Phage Sequencing.

Deliverables

  • FASTQ files
  • Read-length and quality report
  • Assembly results
  • Genomic circular map
  • Analysis of potential mutations
  • Annotation files

CD Genomics leverages the advanced capabilities of the Illumina Platform for precise plasmid sequencing, ensuring reliable verification and comprehensive analysis of plasmid DNA. In addition, we have developed a cost-effective, high-throughput method using Nanopore technology to efficiently sequence larger plasmids in their entirety. Extending our expertise to phage sequencing, we utilize these cutting-edge technologies to provide thorough and accurate genomic insights into bacteriophages. With our extensive experience and state-of-the-art platforms, we are dedicated to delivering exceptional sequencing services and high-quality results tailored to meet the diverse needs of our clients.

The Complete Plasmid DNA Sequencing Results Display Figure.

1. Why is complete plasmid DNA sequencing necessary?

  • Validating sequence integrity: Plasmids may undergo genetic modifications during cloning or amplification, introducing potential errors or mutations.
  • Quality control for cloning and engineering: Sequencing plasmids ensures accurate verification of cloned inserts, absence of mutations, and experimental system integrity.
  • Optimizing experimental design: Accurate plasmid sequences enable effective experimental planning.

2. How to extract plasmid DNA from host cells?

Common extraction methods include:

  • Alkaline lysis: Cell lysis under alkaline conditions to release plasmid DNA.
  • Phenol-chloroform extraction: Utilizing phenol and chloroform for DNA extraction, eliminating proteins and impurities.
  • Column-based extraction: Commercial columns for plasmid DNA purification through centrifugation and elution.

3. How to ensure sequencing data accuracy?

Critical measures to ensure the precision of sequencing data encompass several key procedures:

  • Thorough sample extraction: Guaranteeing the purity and concentration of plasmid DNA.
  • Selecting a suitable sequencing platform: Tailoring the choice to experimental demands.
  • Implementing data processing and quality control: Employing bioinformatics tools to eliminate substandard reads and sequencing errors.
  • Validating through sequence alignment: Aligning the results with known sequences to substantiate accuracy.

4. What are the applications of complete plasmid DNA sequencing?

Complete plasmid DNA sequencing boasts a plethora of applications across various domains:

  • Gene cloning and expression studies: Facilitating the construction of effective cloning vectors.
  • Antibiotic resistance research: Unraveling bacterial resistance mechanisms.
  • Gene function studies: Delving into specific gene functionalities within cells.
  • Synthetic biology and biotechnology: Pioneering the design of synthetic biology tools and pathways for pharmaceutical production, environmental restoration, and bioenergy ventures.

If you would like to learn more, please refer to our article "Plasmid Detection and Complete Plasmid DNA Sequencing."

5. What factors may affect the results of plasmid DNA sequencing?

Influencing factors encompass:

  • Sample quality: DNA purity and concentration adequacy.
  • Sequencing technology: Appropriateness of chosen platforms and technologies.
  • Data processing: Effectiveness of quality control and processing procedures.
  • Sequence complexity: Impact of plasmid sequence complexity and repetitive elements on assembly.

Dynamics of Antimicrobial Resistance and Genomic Epidemiology of Multidrug-Resistant Salmonella enterica Serovar Indiana ST17 from 2006 to 2017 in China

Journal: Msystems

Impact factor: 7.324

Published: 21 July 2022

Background

Nontyphoidal Salmonella enterica (NTS) is a significant global foodborne pathogen, increasingly associated with antimicrobial resistance (AMR), especially multidrug-resistant (MDR) strains. This resistance complicates treatment and poses a public health challenge, leading the WHO to prioritize resistant S. enterica for new antimicrobial development. The genetic basis of resistance includes chromosomal mutations and plasmid-mediated genes, contributing to the widespread dominance of certain strains. Recent studies in China highlight the prevalence and resistance mechanisms of MDR S. Indiana, underscoring the urgent need for effective interventions to curb its spread.

Methods

Sample Preparation:
  • 251 S. Indiana isolates
  • Fecal samples
  • Clinical samples and food-related samples
  • Antimicrobial susceptibility testing
  • DNA extraction
Sequencing:
Data Analysis:
  • Analysis of blaCTX-M genomic locations
  • Phylogenetic analysis

Results

Among 138 blaCTX-M-positive isolates, 65.2% were classified by genome location. Notably, blaCTX-M-14 and blaCTX-M-55 were identified on chromosomes, while blaCTX-M-15 and blaCTX-M-65 were predominantly carried by plasmids. Human isolates exhibited a significantly higher prevalence of blaCTX-M positivity (63%) compared to food-related isolates (47%). Complete sequencing of five representative isolates unveiled a diverse landscape of genetic contexts harboring blaCTX-M genes, particularly on IncHI2 plasmids. Remarkably, plasmid pIndS104-CTX displayed striking similarity to a chromosomal locus in S. Indiana SI43, implying potential recombination events between plasmids and chromosomes. This study underscores the complexity of blaCTX-M dissemination pathways among pathogens and emphasizes the urgent need for further elucidation.

Fig 1. Circular comparison of blaCTX-M-positive IncHI2 plasmids identified in this study (pIndS104-CTX, ps12177-CTX, and ps11011-CTX) with other analogous IncHI2 plasmids cataloged in the NCBI nr database. (Du et al., 2022)Fig 1. Circular comparison between blaCTX-M-positive IncHI2 plasmids in this study (pIndS104-CTX, ps17177-CTX, and ps11011-CTX) and other similar IncHI2 plasmids in the NCBI nr database.

This nationwide study of 251 isolates found strong genomic similarity between human and chicken isolates, suggesting chickens as a source of human infections. Lineage 6 was the most resistant, with IncHI2 plasmids commonly carrying ESBL and PMQR genes.

Conclusion

This study offers a detailed insight into the rapid evolution of multidrug resistance (MDR) in S. Indiana over the past 15 years in China. Unique antimicrobial resistance mechanisms distinguish S. Indiana from other serovars, with diverse genetic processes contributing to resistance development, including chromosomal integrations, evolution of mobile resistance elements, and sporadic acquisition of resistance determinants. The presence of diverse host niches, including various animal reservoirs, underscores the importance of a One Health approach for efficient monitoring and control of resistance spread. Continuous surveillance targeting bacterial strains and mobile genetic elements is essential for effective control measures.

Reference:

  1. Du P, Liu X, Liu Y, et al. Dynamics of antimicrobial resistance and genomic epidemiology of multidrug-resistant Salmonella enterica serovar Indiana ST17 from 2006 to 2017 in China. Msystems, 2022, 7(4): e00253-22.
For Research Use Only. Not for use in diagnostic procedures.
Featured Resources
Related Services
PDF Download
* Email Address:

CD Genomics needs the contact information you provide to us in order to contact you about our products and services and other content that may be of interest to you. By clicking below, you consent to the storage and processing of the personal information submitted above by CD Genomcis to provide the content you have requested.

×
Quote Request
! For research purposes only, not intended for personal diagnosis, clinical testing, or health assessment.
Contact CD Genomics
Terms & Conditions | Privacy Policy | Feedback   Copyright © CD Genomics. All rights reserved.
Top